Orofaciodigital syndrome type 6

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2754OMIM:618763Q04.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Orofaciodigital syndrome type 6 (OFD6), also known as Váradi-Papp syndrome or Váradi syndrome, is a rare autosomal recessive genetic disorder characterized by the combination of oral, facial, and digital anomalies along with cerebellar malformations. It is distinguished from other orofaciodigital syndromes primarily by the presence of a molar tooth sign on brain MRI, reflecting cerebellar vermis hypoplasia or aplasia, which places it within the spectrum of Joubert syndrome and related disorders. Mutations in several genes have been associated with this condition, including C5orf42 (also known as CPLANE1) and TMEM216. Key clinical features include oral findings such as tongue hamartomas (nodules), cleft lip and/or palate, lingual frenula, and dental anomalies. Facial features may include hypertelorism, broad nasal bridge, and midline cleft of the upper lip. Digital anomalies are prominent and include central polydactyly (Y-shaped metacarpal), preaxial and postaxial polydactyly, brachydactyly, and syndactyly. The central nervous system is significantly affected, with cerebellar vermis hypoplasia or aplasia leading to the characteristic molar tooth sign, intellectual disability of variable severity, hypotonia, and ataxia. Some patients may also have hypothalamic hamartomas and other brain malformations. There is no cure for OFD6, and management is supportive and multidisciplinary. Treatment may include surgical correction of cleft lip/palate and polydactyly, speech therapy, physical therapy for motor delays, and educational support for intellectual disability. Neurological monitoring is important given the cerebellar involvement. Genetic counseling is recommended for affected families. Prognosis varies depending on the severity of the central nervous system involvement, with some patients experiencing significant developmental delays while others have milder presentations.

Also known as:

Clinical phenotype terms— hover any for plain English:

Lobulated tongueHP:0000180Abnormal oral frenulum morphologyHP:0000190Tongue nodulesHP:0000199
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Orofaciodigital syndrome type 6.

View clinical trials →

No actively recruiting trials found for Orofaciodigital syndrome type 6 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Orofaciodigital syndrome type 6 community →

No specialists are currently listed for Orofaciodigital syndrome type 6.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Orofaciodigital syndrome type 6.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Orofaciodigital syndrome type 6Forum →

No community posts yet. Be the first to share your experience with Orofaciodigital syndrome type 6.

Start the conversation →

Latest news about Orofaciodigital syndrome type 6

No recent news articles for Orofaciodigital syndrome type 6.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Orofaciodigital syndrome type 6

What is Orofaciodigital syndrome type 6?

Orofaciodigital syndrome type 6 (OFD6), also known as Váradi-Papp syndrome or Váradi syndrome, is a rare autosomal recessive genetic disorder characterized by the combination of oral, facial, and digital anomalies along with cerebellar malformations. It is distinguished from other orofaciodigital syndromes primarily by the presence of a molar tooth sign on brain MRI, reflecting cerebellar vermis hypoplasia or aplasia, which places it within the spectrum of Joubert syndrome and related disorders. Mutations in several genes have been associated with this condition, including C5orf42 (also known

How is Orofaciodigital syndrome type 6 inherited?

Orofaciodigital syndrome type 6 follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Orofaciodigital syndrome type 6 typically begin?

Typical onset of Orofaciodigital syndrome type 6 is neonatal. Age of onset can vary across affected individuals.